Enfusion Newsroom

Piper Sandler Maintains Neutral on Enfusion, Raises Price Target to $11.5

BenzingaDec 23 07:29 ET

Piper Sandler Maintains Enfusion(ENFN.US) With Hold Rating, Raises Target Price to $11.5

Moomoo NewsDec 23 05:31 ET

Enfusion (ENFN) Receives a Hold From Piper Sandler

TipRanksDec 23 04:58 ET

Stifel Maintains Enfusion(ENFN.US) With Buy Rating, Raises Target Price to $13

Moomoo NewsDec 18 15:32 ET

Enfusion Is Maintained at Buy by Stifel

Dow JonesDec 18 12:23 ET

Enfusion Analyst Ratings

BenzingaDec 18 12:13 ET

Morgan Stanley Maintains Enfusion(ENFN.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsNov 5 06:31 ET

Stifel Maintains Enfusion(ENFN.US) With Buy Rating, Raises Target Price to $11

Moomoo NewsNov 4 16:31 ET

Enfusion: Strong Client Acquisitions and Strategic Positioning Drive Buy Rating

TipRanksNov 4 15:38 ET

William Blair Maintains Enfusion(ENFN.US) With Buy Rating

Moomoo NewsNov 4 13:31 ET

William Blair Remains a Buy on Enfusion (ENFN)

TipRanksNov 4 13:16 ET

Analysts' Opinions Are Mixed on These Technology Stocks: International Business Machines (IBM), Salesforce (CRM) and Enfusion (ENFN)

TipRanksSep 22 09:52 ET

William Blair Maintains Enfusion(ENFN.US) With Buy Rating

Moomoo NewsAug 6 14:31 ET

William Blair Sticks to Their Buy Rating for Enfusion (ENFN)

TipRanksAug 6 14:10 ET

Buy Rating Affirmed for Enfusion on Strong Growth and Market Positioning Prospects

TipRanksMay 23 18:30 ET

Analysts Offer Insights on Technology Companies: Enfusion (ENFN), Vertex (VERX) and Shift4 Payments (FOUR)

TipRanksMay 10 05:15 ET

Enfusion (ENFN) Gets a Buy From William Blair

TipRanksMay 9 13:00 ET

Piper Sandler Reaffirms Their Hold Rating on Enfusion (ENFN)

TipRanksApr 10 07:21 ET

Enfusion's Growth Strategy Met With Sell Rating Amid Market and Strategic Challenges

TipRanksMar 21 15:50 ET

Analysts' Opinions Are Mixed on These Technology Stocks: GoDaddy (GDDY) and Enfusion (ENFN)

TipRanksMar 21 08:06 ET